Literature DB >> 1847471

Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.

L F Hu1, J Minarovits, S L Cao, B Contreras-Salazar, L Rymo, K Falk, G Klein, I Ernberg.   

Abstract

Seven virus-coded proteins, the nuclear proteins EBNA-1 to EBNA-6 and the latent membrane protein (LMP), are regularly expressed in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines. In nasopharyngeal carcinoma (NPC), only EBNA-1 is regularly expressed; LMP is detected in about 65% of the tumors. In Burkitt's lymphoma tumors only EBNA-1 is expressed. We have recently shown that the methylation patterns of the EBV genome varied between these cell types. In virally transformed lymphoblastoid cell lines of normal origin, the EBV DNA is completely unmethylated. In contrast, in the Burkitt's lymphoma-derived cell line Rael and in a nude mouse-passaged NPC tumor, C15, there was an extensive methylation of CpG pairs. The methylation extended into the coding regions of the two expressed genes, EBNA-1 (in both tumor types) and LMP (in C15). Two presumptive control regions were exempted from this overall methylation: the oriP that contains both an origin of DNA replication and an EBNA-1-dependent enhancer and the 5'-flanking region of the BNLF-1 open reading frame that codes for LMP. The latter was only exempted in the LMP expressing NPC. We have now investigated the relation between expression of LMP and methylation of DNA in the 5'-flanking 1 kb region of BNLF-1, coding for LMP. LMP was methylated in 3 of 12 NPC biopsies that did not express LMP but was partially or totally unmethylated in the remaining 9 that expressed the protein. The three BNLF-1 exons were highly methylated in all the tumors. The oriP region was unmethylated in all the tumors, as in the previously studied Rael cell line and nude mouse-passaged NPC. Also, the BamHI W enhancer region involved in the expression of EBNA nuclear proteins was methylated. None of the biopsies expressed EBNA-2. Our data show that the EBV genomes are highly methylated in NPC tumors. The strong reverse correlation between the methylation of the putative control region of the LMP gene and the expression of LMP suggests that methylation has a role in the regulation of this gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847471      PMCID: PMC239938     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Understanding the molecular mechanism by which methylation influences gene expression.

Authors:  W S Dynan
Journal:  Trends Genet       Date:  1989-02       Impact factor: 11.639

2.  The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation.

Authors:  V R Baichwal; B Sugden
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

3.  Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II.

Authors:  C Bonnerot; M Daëron; N Varin; S Amigorena; P M Hogarth; J Even; W H Fridman
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

4.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Effect of regional DNA methylation on gene expression.

Authors:  I Keshet; J Yisraeli; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.

Authors:  P B Becker; S Ruppert; G Schütz
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

7.  Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.

Authors:  F Watt; P L Molloy
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

8.  The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated.

Authors:  D E Kelley; B A Pollok; M L Atchison; R P Perry
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

9.  A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Authors:  K Hennessy; S Fennewald; M Hummel; T Cole; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  EBV gene expression in an NPC-related tumour.

Authors:  M M Hitt; M J Allday; T Hara; L Karran; M D Jones; P Busson; T Tursz; I Ernberg; B E Griffin
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  25 in total

1.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Authors:  E Altiok; J Minarovits; L F Hu; B Contreras-Brodin; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

3.  The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.

Authors:  J Sample; E B Henson; C Sample
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Modulation of LMP1 protein expression by EBV-encoded microRNAs.

Authors:  Angela Kwok Fung Lo; Ka Fai To; Kwok Wai Lo; Raymond Wai Ming Lung; Jan Wai Ying Hui; Gangling Liao; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

5.  Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.

Authors:  A J Sinclair; I Palmero; A Holder; G Peters; P J Farrell
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Evidence that protein binding specifies sites of DNA demethylation.

Authors:  C L Hsieh
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.

Authors:  R Khanna; S R Burrows; D J Moss; S L Silins
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.

Authors:  S Imai; S Koizumi; M Sugiura; M Tokunaga; Y Uemura; N Yamamoto; S Tanaka; E Sato; T Osato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line.

Authors:  Jun Nishikawa; Lorand L Kis; Anquan Liu; Xiangning Zhang; Miki Takahara; Kentaro Bandobashi; Csaba Kiss; Noemi Nagy; Kiwamu Okita; George Klein; Eva Klein
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

10.  Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?

Authors:  S Karlin; W Doerfler; L R Cardon
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.